Bionano Genomics (BNGO) Acquisitions (2020 - 2022)

Bionano Genomics (BNGO) has 3 years of Acquisitions data on file, last reported at $32.0 million in Q4 2022.

• For the quarter ending Q4 2022, Acquisitions fell 34.73% year-over-year to $32.0 million; the trailing twelve-month figure through Dec 2022 stood at $31.3 million (down 36.14% YoY), and the FY2022 full-year result was $31.3 million, down 36.14% from the prior year.
• Acquisitions rose to $32.0 million in Q4 2022, from -$694000.0 in the prior quarter.
• In the past five years, Acquisitions ranged from a high of $49.1 million in Q4 2021 to a low of -$2.4 million in Q4 2020.
• A 3-year average of $19.5 million and a median of $15.7 million in 2022 frame the typical range for Acquisitions.
• Across the five-year window, Acquisitions jumped 2103.51% in 2021 and slumped 34.73% in 2022, its largest moves.
• Tracing BNGO's Acquisitions over 3 years: stood at -$2.4 million in 2020, then jumped by 2103.51% to $49.1 million in 2021, then tumbled by 34.73% to $32.0 million in 2022.
• Business Quant data shows BNGO's Acquisitions at $32.0 million in Q4 2022, -$694000.0 in Q1 2022, and $49.1 million in Q4 2021.